Status: Recruiting
Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of MPD-1 in Patients With Advanced Solid Tumor
A Phase I, Open-label, Single-center, Dose-escalation and Dose-finding Clinical trial to evaluate the safety, tolerability and pharmacokinetics of MPD-1 in patients with advanced solid tumor
Participants needed: 24
Trial details
Phase: Phase 1Age: 19-75Biological sex: AllType: InterventionalSponsor: Pharosgen Co.,LtdUpdated: Apr 25, 2025Locations: 1
Eligibility criteria
19 to 75 years of age [+14]
Within 4 weeks prior to the C1D1, subjects who underwent surgery, chemotherapy (... [+23]